Analysis of bone marrow samples from nine refractory/relapsed AML patients showed a higher proportion (22%) of CD8-positive T cells co-expressing PD-1 and larger T-cell clonal expansion measured by T-cell receptor rearrangement compared with healthy donor samples [18]. This evidence concerns the gene CD8A and acute myeloid leukemia.